Historical insights into cytokines

European Journal of Immunology

Volumn 37, Issue SUPPL. 1, 2007, Pages

  Dinarello, Charles A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Autoimmune; Host response; Infection; Inflammation; Leukocytes

Indexed keywords

ACETYLSALICYLIC ACID; ADIPOCYTOKINE; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BETA INTERFERON; CD20 ANTIBODY; CHEMOKINE; CYTOKINE; CYTOKINE ANTIBODY; CYTOKINE RECEPTOR ANTAGONIST; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ERYTHROPOIETIN; GENE PRODUCT; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; IMMUNOGLOBULIN; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12 ANTIBODY; INTERLEUKIN 1BETA ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 6 ANTIBODY; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGING; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; AUTOINFLAMMATORY DISEASE; BONE MARROW SUPPRESSION; CANCER; CELL DIFFERENTIATION; CELL POLARITY; CLINICAL TRIAL; COGNITION; CYTOKINE PRODUCTION; DISEASE CLASSIFICATION; DRUG EFFICACY; EMBRYO DEVELOPMENT; GENE DELETION; GENETIC SCREENING; GRAFT REJECTION; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOGENETICS; IMMUNOLOGY; IMMUNOPATHOGENESIS; INFECTION; INFLAMMATION; MULTIPLE SCLEROSIS; NONHUMAN; OUTCOMES RESEARCH; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; STEM CELL; TH1 CELL; TH2 CELL; TREATMENT PLANNING; VACCINATION; VIRAL GENETICS;

ALLERGY AND IMMUNOLOGY; ANIMALS; CYTOKINES; HISTORY, 20TH CENTURY; HUMANS;

EID: 36248974200     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737772     Document Type: Review

References (67)

1. Jin, Y., Mailloux, C. M., Gowan, K., Riccardi, S. L., LaBerge, G., Bennett, D. C., Fain, P. R. and Spritz, R. A., NALP1 in vitiligo-associated multiple autoimmune disease. N. Engl. J. Med. 2007 356: 1216-1225.
2. Hoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A. and Kolodner, R. D., Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat. Genet. 2001. 29: 301-305.
3. Bernheim, H. A. and Kluger, M. J., Fever and antipyresis in the lizard Dipsosaurus dorsalis. Am. J. Physiol. 1976. 231: 198-203.
4. Gery, I. and Waksman, B. H., Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s). J. Exp. Med. 1972. 136: 143-155.
5. Mier, J. W. and Gallo, R. C., Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media. Proc. Natl. Acad. Sci. USA 1980. 77: 6134-6138.
6. Pizarro, T. T. and Cominelli, F., Cloning IL-1 and the birth of a new era in cytokine biology. J. Immunol. 2007. 178: 5411-5412.
7. Sims, J. E., March, C. J., Cosman, D., Widmer, M. B., MacDonald, H. R., McMahan, C. J., Grubin, C. E. et al., cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 1988. 241: 585-589.
8. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G. et al., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005. 23: 479-490.
9. Leung, B. P., Xu, D., Culshaw, S., McInnes, I. B. and Liew, F. Y., A novel therapy of murine collagen-induced arthritis with soluble T1/ ST2. J. Immunol. 2004. 173: 145-150.
10. Netea, M. G., Joosten, L. A., Lewis, E., Jensen, D. R., Voshol, P. J., Kullberg, B. J., Tack, C. J. et al., Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat. Med. 2006. 12: 650-656.
11. Kim, S. H., Han, S. Y., Azam, T., Yoon, D. Y. and Dinarello, C. A., Interleukin-32: A cytokine and inducer of TNFalpha. Immunity 2005. 22: 131-142.
12. Joosten, L. A., Netea, M. G., Kim, S. H., Yoon, D. Y., Oppers-Walgreen, B., Radstake, T. R., Barrera, P. et al., IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 2006. 103: 3298-3303.
13. Eichacker, P. Q., Parent, C., Kalil, A., Esposito, C., Cui, X., Banks, S. M., Gerstenberger, E. P. et al., Risk and the efficacy of antiinflammatory agents: Retrospective and confirmatory studies of sepsis. Am. J. Respir. Crit. Care Med. 2002. 166: 1197-1205.
14. Kosiewicz, M. M., Nast, C. C., Krishnan, A., Rivera-Nieves, J., Moskaluk, C. A., Matsumoto, S., Kozaiwa, K. and Cominelli, F., Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease. J. Clin. Invest. 2001. 107: 695-702.
15. Werman, A., Werman-Venkert, R., White, R., Lee, J. K., Werman, B., Krelin, Y., Voronov, E. et al., The precursor form of IL-1α is an intracrine proinflammatory activator of transcription. Proc. Natl. Acad. Sci. USA 2004. 101: 2434-2439.
16. Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A. et al., HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999. 285: 248-251.
17. Carriere, V., Roussel, L., Ortega, N., Lacorre, D. A., Americh, L., Aguilar, L., Bouche, G. and Girard, J. P., IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA 2007. 104: 282-287.
18. Nakanishi, K., Yoshimoto, T., Tsutsui, H. and Okamura, H., Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 2001. 12: 53-72.
19. Lewis, E. C. and Dinarello, C. A., Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor. Proc. Natl. Acad. Sci. USA 2006. 103: 16852-16857.
20. Zorrilla, E. P., Sanchez-Alavez, M., Sugama, S., Brennan, M., Fernandez, R., Bartfai, T. and Conti, B., Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc. Natl. Acad. Sci. USA 2007. 104: 11097-11102.
21. Tsutsui, H., Kayagaki, N., Kuida, K., Nakano, H., Hayashi, N., Takeda, K., Matsui, K. et al., Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 1999. 11: 359-367.
22. Lau, D. C. W., Dhillon, B., Yan, H., Szmitko, P. E. and Verma, S., Adipokines: Molecular links between obesity and atherosclerosis. Am. J. Physiol. 2005. 288: 2031-2041.
23. Kamari, Y., Werman-Venkert, R., Shaish, A., Werman, A., Harari, A., Gonen, A., Voronov, E. et al, Differential role and tissue specificity of interleukin-1 alpha gene expression in atherogenesis and lipid metabolism. Atherosclerosis 2006. doi:10.1016/ j.atherosclerosis.2006.11.026.
24. Fantuzzi, G., Adipose tissue, adipokines and inflammation. J. Allergy Clin. Immunol. 2005. 115: 911-919.
25. Mandrup-Poulsen, T., Bendtzen, K., Nerup, J., Dinarello, C. A., Svenson, M. and Nielsen, J. H., Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia 1986. 29: 63-67.
26. Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N. et al., Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J. Clin. Invest. 2002. 110: 851-860.
27. Larsen, C. M., Faulenbach, M., Vaag, A., Volund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T. and Donath, M. Y., Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 2007. 356: 1517-1526.
28. Smith, J. W., Longo, D., Alford, W. G., Janik, J. E., Sharfman, W. H., Gause, B. L., Curti, B. D. et al., The effects of treatment with interleukin-1α on platelet recovery after high-dose carboplatin. N. Engl. J. Med. 1993. 328: 756-761.
29. Kaplanski, G., Farnarier, C., Kaplanski, S., Porat, R., Shapiro, L., Bongrand, P. and Dinarello, C. A., Interleukin-1 induces interleukin-8 from endothelial cells by a juxacrine mechanism. Blood 1994. 84: 4242-4248.
30. Apte, R. N., Douvdevani, A., Zoller, M., Dvorkin, T., Shimoni, S., Fima, E., Hacham, M. et al., Cytokine-induced tumorogenicity: Endogenous interleukin-1α expressed by fibrosarcoma cells confers reduced tumorogenicity. Immunol. Lett. 1993. 39: 45-52.
31. Ray, C. A., Black, R. A., Kronheim, S. R., Greenstreet, T. A., Sleath, P. R., Salvesen, G. S. and Pickup, D. J., Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell 1992. 69: 597-604.
32. Novick, D., Kim, S.-H., Fantuzzi, G., Reznikov, L., Dinarello, C. A. and Rubinstein, M., Interleukin-18 binding protein: A novel modulator of the Th1 cytokine response. Immunity 1999. 10: 127-136.
33. Xiang, Y. and Moss, B., Correspondence of the functional epitopes of poxvirus and human interleukin-18-binding proteins. J. Virol. 2001. 75: 9947-9954.
34. Engelmann, H., Novick, D. and Wallach, D., Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J. Biol. Chem. 1990. 265: 1531-1536.
35. Girardin, E., Roux-Lombard, P., Grau, G. E., Suter, P., Gallati, H., Group, J. S. and Dayer, J.-M., Imbalance between tumor necrosis factor-α and soluble TNF receptor concentrations in severe meningococcemia. Immunology 1992. 76: 20-23.
36. Colotta, F., Dower, S. K., Sims, J. E. and Mantovani, A., The type II "decoy" receptor: A novel regulatory pathway for interleukin-1. Immunol. Today 1994. 15: 562-566.
37. Horai, R., Saijo, S., Tanioka, H., Nakae, S., Sudo, K., Okahara, A., Ikuse, T. et al., Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J. Exp. Med. 2000. 191: 313-320.
38. Netea, M. G., Puren, A. J. and Dinarello, C. A., A short course of oral aspirin increases IL-18-induced interferon-gamma production in whole blood cultures. Eur. Cytokine Netw. 2000. 11: 379-382.
39. Endres, S., Ghorbani, R., Kelley, V. E., Georgilis, K., Lonnemann, G., van der Meer, J. W., Cannon, J. G. et al., The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N. Engl. J. Med. 1989. 320: 265-271.
40. Goldbach-Mansky, R., Dailey, N. J., Canna, S. W., Gelabert, A., Jones, J., Rubin, B. I., Kim, H. J. et al., Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N. Engl. J. Med. 2006. 355: 581-592.
41. Hawkins, P. N., Lachmann, H. J., Aganna, E. and McDermott, M. F., Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthr. Rheumat. 2004. 50: 607-612.
42. Hoffman, H. M., Rosengren, S., Boyle, D. L., Cho, J. Y., Nayar, J., Mueller, J. L., Anderson, J. P. et al., Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 2004. 364: 1779-1785.
43. Andrei, C., Margiocco, P., Poggi, A., Lotti, L. V., Torrisi, M. R. and Rubartelli, A., Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: Implications for inflammatory processes. Proc. Natl. Acad. Sci. USA 2004. 101: 9745-9750.
44. Greenfeder, S. A., Nunes, P., Kwee, L., Labow, M., Chizzonite, R. A. and Ju, G., Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex. J. Biol. Chem. 1995. 270: 13757-13765.
45. Casadio, R., Frigimelica, E., Bossu, P., Neumann, D., Martin, M. U., Tagliabue, A. and Boraschi, D., Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1beta/IL-1R(I) complex. FEBS Lett. 2001. 499: 65-68.
46. Leonard, W. J., Depper, J. M., Uchiyama, T., Smith, K. A., Waldmann, T. A. and Greene, W. C., A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature 1982. 300: 267-269.
47. Smith, K. A., T-cell growth factor. Immunol. Rev. 1980. 51: 337-357.
48. Kishimoto, T. and Hirano, T., A new interleukin with pleiotropic activities. Bioessays 1988. 9: 11-15.
49. Beeson, P. B., Temperature-elevating effect of a substance obtained from polymorphonuclear leucocytes. J. Clin. Invest. 1948. 27: 524.
50. Atkins, E. and Wood, W. B., Jr., Studies on the pathogenesis of fever. I. The presence of transferable pyrogen in the blood stream following the injection of typhoid vaccine. J. Exp. Med. 1955. 101: 519-528.
51. Murphy, P. A., Chesney, P. J. and Wood, W. B., Jr., Further purification of rabbit leukocyte pyrogen. J. Lab. Clin. Med. 1974. 83: 310-322.
52. Dinarello, C. A., Renfer, L. and Wolff, S. M., Human leukocytic pyrogen: Purification and development of a radioimmunoassay. Proc. Natl. Acad. Sci. USA 1977. 74: 4624-4627.
53. Remold, H. G., Katz, A. B., Haber, E. and David, J. R., Studies on migration inhibitory factor (MIF): Recovery of MIF activity after purification by gel filtration and disc electrophoresis. Cell. Immunol. 1970. 1: 133-145.
54. Dayer, J. M., Graham, R., Russell, G. and Krane, S. M., Collagenase production by rheumatoid synovial cells: Stimulation by a human lymphocyte factor. Science 1977. 195: 181-183.
55. Saklatvala, J., Sarsfield, S. J. and Townsend, Y., Pig interleukin 1: Purification of two immunologically different leukocyte proteins that cause cartilage resorption, lymphocyte activation, and fever. J. Exp. Med. 1985. 162: 1208-1222.
56. Kampschmidt, R. F., Leukocytic endogenous mediator/endogenous pyrogen.In Powanda, M. C. and Canonico, P. G. (Eds.) The physiologic and metabolic responses of the host. Elsevier, Amsterdam 1981, pp 55-74.
57. Moldawer, L. L., Andersen, C., Gelin, J. and Lundholm, K. G., Regulation of food intake and hepatic protein synthesis by recombinant derived cytokines. Am. J. Physiol. 1988. 254: G450-G456.
58. Rosenwasser, L. J., Dinarello, C. A. and Rosenthal, A. S., Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic pyrogen. J. Exp. Med. 1979. 150: 709-714.
59. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N. and Williamson, B., An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 1975. 72: 3666-3670.
60. Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y. C., Mathison, J., Ulevitch, R. and Cerami, A., Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 1985. 316: 552-554.
61. Howard, M. and Paul, W. E., Interleukins for B lymphocytes. Lymphokine Res. 1982. 1: 1-4.
62. Baggiolini, M., Walz, A. and Kunkel, S. L., Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 1989. 84: 1045-1049.
63. Matsushima, K. and Oppenheim, J. J., Interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1989. 1: 2-13.
64. Lewis, E. C., Shapiro, L., Bowers, O. J. and Dinarello, C. A., Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc. Natl. Acad. Sci. USA 2005. 102: 12153-12158.
65. Janciauskiene, S. M., Nita, I. M. and Stevens, T., Alpha1-antitrypsin, old dog, new tricks. Alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J. Biol. Chem. 2007 282: 8573-8582.
66. Munch, J., Standker, L., Adermann, K., Schulz, A., Schindler, M., Chinnadurai, R., Pohlmann, S. et al., Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell 2007. 129: 263-275.
67. Shapiro, L., Pott, G. B. and Ralston, A. H., Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1. Faseb J. 2001. 15: 115-122.